ARKE HEALTH
DEAD

Serial Number

97583755

Owner

Red Cell Partners, LLC

Attorney

Aaron Y. Silverstein

Filing Date

Sep 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ARKE HEALTH Trademark

Serial Number: 97583755

ARKE HEALTH is a trademark filed by Red Cell Partners, LLC on September 8, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Red Cell Partners, LLC (31 trademarks)

Suite A-120
McLean, VA 22102

Entity Type: 16

Trademark Details

Filing Date

September 8, 2022

Registration Date

Not Registered

Published for Opposition

May 21, 2024

Goods & Services

Downloadable or recorded computer programs using artificial intelligence for machine learning; downloadable computer software using artificial intelligence and machine learning for inputting, collecting, analyzing, storing, managing, recording, authenticating, transmitting, and receiving data for health treatment and diagnostic purposes; downloadable computer programs using artificial intelligence for machine learning in the fields of healthcare, medicine genetics, biology, life sciences, biotechnology, drug development, research and development, insurance, and pharmaceuticals

Healthcare ecosystem, namely, procuring and fulfilling government contracts in the field of healthcare utilizing artificial intelligence and machine learning technologies; Healthcare ecosystem, namely, procuring, subcontracting, and maintaining business and contractual relationships in the field of healthcare

Scientific and product research and development services; drug discovery services in the nature of pharmaceutical research and development services; biotechnology research, consulting and development; providing temporary use of online non-downloadable software using machine learning algorithms for inputting, collecting, analyzing, storing, managing, recording, authenticating, transmitting, and receiving data for health treatment and diagnostic purposes; providing temporary use of online non-downloadable software and non-downloadable software platforms in the fields of healthcare, medicine, genetics, biology, life sciences, biotechnology, drug development, research and development, insurance, and pharmaceuticals that also include the use of artificial intelligence and machine learning for inputting, collecting, analyzing, storing, managing, recording, authenticating, transmitting, and receiving data for health treatment and diagnostic purposes; scientific research, product development, and scientific research consulting in the fields of healthcare, medicine, genetics, biology, life sciences, biotechnology, drug development, and pharmaceuticals; consulting services in the field of healthcare, medicine, genetics, biology, life sciences, biotechnology, drug development, and pharmaceuticals; pharmaceutical research and drug development services; providing scientific and medical research information in the field of genetics, biology, life sciences, biotechnology, drug development, and pharmaceuticals; providing interactive websites featuring technology in the fields of healthcare, medicine, genetics, biology, life sciences, biotechnology, drug development, research and development, insurance, and pharmaceuticals that also includes the use of artificial intelligence, and machine learning for inputting, collecting, analyzing, storing, managing, recording, authenticating, transmitting, and receiving data for health treatment and diagnostic purposes; providing online databases featuring information relating to scientific and medical research in the fields of healthcare, medicine, genetics, biology, life sciences, biotechnology, drug development, research and development, insurance, and pharmaceuticals that also includes the use of artificial intelligence, and machine learning

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 17, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 17, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 16, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 15, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 10, 2024 ERFR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 16, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 16, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 16, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 16, 2024 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 26, 2024 GNFN
FINAL REFUSAL E-MAILED
Jan 26, 2024 GNFR
FINAL REFUSAL WRITTEN
Jan 26, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 16, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 13, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 13, 2023 XELR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 22, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 22, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 22, 2023 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 13, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 13, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 13, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 29, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 29, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 27, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 27, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 4, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jan 4, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jan 4, 2023 CNRT
ASSIGNED TO EXAMINER
Jan 2, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 26, 2022 NWOS
NEW APPLICATION ENTERED
Sep 12, 2022 NWAP